InterSystems partnered with ImmunoPrecise Antibodies (IPA). IPA has just recently announced a partnership with InterSystems. This collaboration merges the vector search feature of the InterSystems IRIS® data platform with IPA's BioStrand subsidiary's LENSai platform, establishing a new benchmark for AI-powered solutions in healthcare and life sciences. One of the key advantages of this integration is the ability to perform more precise and in-depth data analysis.

With the combined power of Vector Search and LENSai, researchers can now conduct more accurate and meaningful searches across vast repositories of unstructured biological data. By harnessing the capabilities of both platforms, researchers can leverage advanced search algorithms and AI-driven technologies to identify novel therapeutic targets more efficiently. This streamlined process reduces the time from initial discovery to the commencement of clinical trials, potentially bringing life-saving treatments to patients faster.